Target Price | €32.54 |
Price | €33.20 |
Deviation | 1.99% |
Number of Estimates | 5 |
5 Analysts have issued a price target Lenzing 2026 . The average Lenzing target price is €32.54. This is 1.99% lower than the current stock price. The highest price target is €35.00 5.42% , the lowest is €30.00 9.64% . | |
A rating was issued by 5 analysts: 0 Analysts recommend Lenzing to buy, 5 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Lenzing stock has an average upside potential 2026 of 1.99% . Most analysts recommend the Lenzing stock at Hold. |
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion € | 2.66 | 2.83 |
5.66% | 6.11% | |
EBITDA Margin | 11.57% | 15.23% |
115.46% | 31.68% | |
Net Margin | -5.89% | -0.85% |
80.81% | 85.56% |
5 Analysts have issued a sales forecast Lenzing 2025 . The average Lenzing sales estimate is €2.8b . This is 6.11% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €3.3b 23.84% , the lowest is €2.7b 0.11% .
This results in the following potential growth metrics:
2024 | €2.7b | 5.66% |
---|---|---|
2025 | €2.8b | 6.11% |
2026 | €2.9b | 2.93% |
2027 | €2.8b | 2.40% |
2028 | €3.0b | 5.22% |
5 Analysts have issued an Lenzing EBITDA forecast 2025. The average Lenzing EBITDA estimate is €431m . This is 26.49% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €458m 34.46% , the lowest is €401m 17.79% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | €308m | 127.66% |
---|---|---|
2025 | €431m | 39.76% |
2026 | €495m | 14.95% |
2027 | €521m | 5.27% |
2028 | €595m | 14.19% |
2024 | 11.57% | 115.46% |
---|---|---|
2025 | 15.23% | 31.68% |
2026 | 17.01% | 11.69% |
2027 | 18.35% | 7.88% |
2028 | 19.91% | 8.50% |
5 Lenzing Analysts have issued a net profit forecast 2025. The average Lenzing net profit estimate is €-24.1m . This is 84.62% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €9.5m 106.05% , the lowest is €-67.5m 56.94% .
This results in the following potential growth metrics and future Net Margins:
2024 | €-157m | 79.72% |
---|---|---|
2025 | €-24.1m | 84.62% |
2026 | €48.5m | 301.24% |
2027 | €25.7m | 46.99% |
2028 | €91.9m | 257.25% |
2024 | -5.89% | 80.81% |
---|---|---|
2025 | -0.85% | 85.56% |
2026 | 1.67% | 296.47% |
2027 | 0.91% | 45.51% |
2028 | 3.08% | 238.46% |
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | -4.06 | -0.62 |
79.72% | 84.73% | |
P/E | negative | |
EV/Sales | 1.34 |
5 Analysts have issued a Lenzing forecast for earnings per share. The average Lenzing EPS is €-0.62 . This is 84.73% higher than earnings per share in the financial year 2024. The highest EPS forecast is €0.25 106.16% , the lowest is €-1.75 56.90% .
This results in the following potential growth metrics and future valuations:
2024 | €-4.06 | 79.72% |
---|---|---|
2025 | €-0.62 | 84.73% |
2026 | €1.26 | 303.23% |
2027 | €0.67 | 46.83% |
2028 | €2.38 | 255.22% |
Current | -8.19 | 186.36% |
---|---|---|
2025 | -53.16 | 549.08% |
2026 | 26.42 | 149.70% |
2027 | 49.82 | 88.57% |
2028 | 13.95 | 72.00% |
Based on analysts' sales estimates for 2025, the Lenzing stock is valued at an EV/Sales of 1.34 and an P/S ratio of 0.45 .
This results in the following potential growth metrics and future valuations:
Current | 1.42 | 2.90% |
---|---|---|
2025 | 1.34 | 5.94% |
2026 | 1.30 | 2.85% |
2027 | 1.33 | 2.46% |
2028 | 1.26 | 4.96% |
Current | 0.48 | 22.03% |
---|---|---|
2025 | 0.45 | 5.76% |
2026 | 0.44 | 2.84% |
2027 | 0.45 | 2.45% |
2028 | 0.43 | 4.96% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.